ES439141A1 - Alkenylxanthines and their conversion to hydroxyalkylxanthines - Google Patents
Alkenylxanthines and their conversion to hydroxyalkylxanthinesInfo
- Publication number
- ES439141A1 ES439141A1 ES439141A ES439141A ES439141A1 ES 439141 A1 ES439141 A1 ES 439141A1 ES 439141 A ES439141 A ES 439141A ES 439141 A ES439141 A ES 439141A ES 439141 A1 ES439141 A1 ES 439141A1
- Authority
- ES
- Spain
- Prior art keywords
- atoms
- prepared
- radicals
- alkenylxanthines
- monoalkenyldialkylxanthines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
Abstract
In the process there are prepared novel monoalkenyldialkylxanthines of the general formula I < IMAGE > One of the radicals R<1>, R<2> and R<3> is ( omega -1)-alken-1-yl having 4 to 8 C atoms, which does not have a branch in the ( omega -1)-position. The two other radicals are alkyl having 1 to 12 C atoms. According to the invention, a 1-halo-C4-C8-alkene having a terminal double bond, but not one containing a tertiary C atom, is reacted with an appropriate alkali metal salt of a dialkylxanthine. Haloalkenes having an unbranched carbon chain are preferably employed. Monoalkenyldialkylxanthines of the formula I may expediently be prepared in which one of the two alkyl radicals has 2 to 12 C atoms. The alkenylxanthines prepared are useful as starting substances for the preparation of therapeutically utilisable hydroxyalkylxanthine compounds, of which e.g. 1-(5'-hydroxyhexyl)theobromine is distinguished by promotion of the circulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48587074A | 1974-07-05 | 1974-07-05 | |
US05/485,869 US4108995A (en) | 1973-07-11 | 1974-07-05 | Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines |
Publications (1)
Publication Number | Publication Date |
---|---|
ES439141A1 true ES439141A1 (en) | 1977-02-16 |
Family
ID=27048497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES439141A Expired ES439141A1 (en) | 1974-07-05 | 1975-07-04 | Alkenylxanthines and their conversion to hydroxyalkylxanthines |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS5250800B2 (en) |
AR (1) | AR210330A1 (en) |
AT (1) | AT339917B (en) |
CA (1) | CA1062710A (en) |
CH (2) | CH622519A5 (en) |
DK (1) | DK140214B (en) |
ES (1) | ES439141A1 (en) |
FI (1) | FI59249C (en) |
FR (1) | FR2277089A1 (en) |
GB (1) | GB1500039A (en) |
LU (1) | LU72897A1 (en) |
NL (1) | NL166476C (en) |
NO (1) | NO143224C (en) |
SE (2) | SE420097B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU197569B (en) * | 1984-01-12 | 1989-04-28 | Sandoz Ag | Process for producing 8alpha-acylaminoergoline derivatives and pharmaceuticals comprising such compounds |
DE3525801A1 (en) * | 1985-07-19 | 1987-01-22 | Hoechst Ag | TERTIA HYDROXYALKYLXANTHINE, METHOD FOR THE PRODUCTION THEREOF, THE MEDICINAL PRODUCT CONTAINING IT AND THEIR USE |
EP0570831A2 (en) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation |
-
1975
- 1975-07-02 CH CH859275A patent/CH622519A5/en not_active IP Right Cessation
- 1975-07-03 JP JP50081475A patent/JPS5250800B2/ja not_active Expired
- 1975-07-03 DK DK301775AA patent/DK140214B/en not_active IP Right Cessation
- 1975-07-03 LU LU72897A patent/LU72897A1/xx unknown
- 1975-07-04 FI FI751958A patent/FI59249C/en not_active IP Right Cessation
- 1975-07-04 ES ES439141A patent/ES439141A1/en not_active Expired
- 1975-07-04 AT AT517275A patent/AT339917B/en not_active IP Right Cessation
- 1975-07-04 GB GB28341/75A patent/GB1500039A/en not_active Expired
- 1975-07-04 CA CA230,790A patent/CA1062710A/en not_active Expired
- 1975-07-04 SE SE7507726A patent/SE420097B/en not_active IP Right Cessation
- 1975-07-04 FR FR7521043A patent/FR2277089A1/en active Granted
- 1975-07-04 AR AR258487A patent/AR210330A1/en active
- 1975-07-04 NO NO752423A patent/NO143224C/en unknown
- 1975-07-04 NL NL7507976.A patent/NL166476C/en not_active IP Right Cessation
-
1978
- 1978-07-14 SE SE7807853A patent/SE427183B/en not_active IP Right Cessation
-
1980
- 1980-04-29 CH CH331680A patent/CH622018A5/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1062710A (en) | 1979-09-18 |
SE427183B (en) | 1983-03-14 |
GB1500039A (en) | 1978-02-08 |
NO752423L (en) | 1976-01-06 |
SE7507726L (en) | 1976-01-07 |
FI59249C (en) | 1981-07-10 |
FR2277089A1 (en) | 1976-01-30 |
JPS5134194A (en) | 1976-03-23 |
NO143224B (en) | 1980-09-22 |
ATA517275A (en) | 1977-03-15 |
SE420097B (en) | 1981-09-14 |
LU72897A1 (en) | 1976-05-31 |
FR2277089B1 (en) | 1978-03-17 |
NL7507976A (en) | 1976-01-07 |
AU8275575A (en) | 1977-01-06 |
NL166476B (en) | 1981-03-16 |
JPS5250800B2 (en) | 1977-12-27 |
DK140214B (en) | 1979-07-09 |
DK301775A (en) | 1976-01-06 |
FI59249B (en) | 1981-03-31 |
AT339917B (en) | 1977-11-10 |
NL166476C (en) | 1981-08-17 |
AR210330A1 (en) | 1977-07-29 |
CH622519A5 (en) | 1981-04-15 |
DK140214C (en) | 1979-12-03 |
CH622018A5 (en) | 1981-03-13 |
SE7807853L (en) | 1978-07-14 |
FI751958A (en) | 1976-01-06 |
NO143224C (en) | 1981-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1377225A (en) | Acylanilino compounds and herbicidal compositions containing them | |
ES8507507A1 (en) | Substituted 2-mercapto-imidazoles and their preparation and use. | |
KR870006039A (en) | Novel thiazole compound, preparation method thereof and pharmaceutical composition containing the compound | |
ES437997A1 (en) | X-ray contrast media | |
ES431055A1 (en) | N-{8 (Methoxymethyl-furyl)-methyl{9 -morphinans or -6,7-benzomorphans and salts thereof | |
UA7228A1 (en) | Method for synthesizing derivatives of n-(4-indolylpiperidine alkyl) benzimidazolon or their salts | |
CH614448A5 (en) | Process for the preparation of novel tertiary amines and their acid addition salts, and compounds thus prepared | |
GB1369999A (en) | Monomethyl-amino-triidobenzene compounds for use as x-ray shading agents | |
ES437150A1 (en) | Hydroxyhexyl-alkylxanthines and pharmaceutical compositions containing hydroxyhexyl-alkylxanthines | |
ES439141A1 (en) | Alkenylxanthines and their conversion to hydroxyalkylxanthines | |
FR2358141A1 (en) | NEW LOCAL ANESTHESICS | |
GB1409733A (en) | Triiodinated n-methyl-dicarboxylic acid anilides and process for their manufacture | |
GB1350732A (en) | Hydroxyalkylamino-alkylamides and their preparation | |
GB1231168A (en) | ||
ES423233A1 (en) | 2-phenylamino-imidazolines-(2) | |
HUT37116A (en) | Process for production of phenil-alanin derivatives | |
ES8507123A1 (en) | 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine derivatives, process for their preparation and their therapeutical use | |
GB845486A (en) | Improvements in or relating to 2-diarylalkyl-3,4,5,6-tetrahydropyrimidines | |
ES430208A1 (en) | Imidazolidine derivatives | |
ES388822A1 (en) | Biocidal composition and disinfecting method | |
GB1325944A (en) | Bisoxalic acid diamides | |
ES451375A1 (en) | 2,4-diamino-5-benzylpyrimidines | |
GB1254928A (en) | beta-ALKOXYACRYLIC ACID AMIDES | |
ES381820A1 (en) | Substituted bicycloalkanes their preparation compositions containing same and their use | |
ES430102A2 (en) | Phenylacetic acid derivatives |